How will the new EU General Data Protection Regulation (GDPR) affect my clinical trial?
How do you cope with data protection and data privacy in your database?
Manage and shape your health and research project with staicy’s intuitive design and made-to-measure modules. staicy’s patented geo-storage feature allows you to store your data where you want it and abide with current data and privacy regulations.
If sponsors want to enroll and retain patients, they must take steps to mediate the information overload & falsehoods that their patients are exposed to and continue to establish trusting relationships with them. Using the correct guidance as a road map, sponsors can work to drive recruitment, enrollment and completion of their trials with more robust data at a lower cost and reach their goals of regulatory approval at a faster rate.
The idea of “fake news” has pervaded the way in which we view world news. As a result, the veracity of any claim can easily be called into question. In a survey of brands and companies, 42% of Americans believe they are not as truthful as they were 20 years ago. The idea of false information is not new, but the reaction it elicits is stronger than ever seen before.
Often described as the most important development in data privacy regulation, the General Data Protection Regulation is intended to strengthen data security for individuals. View this 30 min. webinar to better understand how clinical trials are impacted by the GDPR.
The General Data Protection Regulation or GDPR is effective as of 25 May 2018 and it will bring substantial changes to the way medical device manufacturers and sponsors will collect and process personal data, including data concerning health.
If sponsors want to enroll and retain patients, they must take steps to mediate the information overload & falsehoods that their patients are exposed to and continue to establish trusting relationships with them. Download this white paper and discover the most important factors in successfully driving recruitment, enrollment and completion of your clinical trials.